|
FAM177A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
5.50129999999927E-05 |
| Normal-vs-Stage3 |
1.24660004541255E-09 |
| Normal-vs-Stage4 |
2.35919999999057E-05 |
| Stage1-vs-Stage2 |
1.475960E-01 |
| Stage1-vs-Stage3 |
5.025900E-02 |
| Stage1-vs-Stage4 |
4.336100E-02 |
| Stage2-vs-Stage3 |
8.621600E-01 |
| Stage2-vs-Stage4 |
8.271400E-01 |
| Stage3-vs-Stage4 |
6.558200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
4.66590000003375E-06 |
| Normal-vs-Asian |
5.75549999992653E-07 |
| Caucasian-vs-AfricanAmerican |
4.746000E-01 |
| Caucasian-vs-Asian |
7.385000E-01 |
| AfricanAmerican-vs-Asian |
6.733800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.94959612290313E-11 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
7.504000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
9.92106397035286E-12 |
| Normal-vs-Age(61-80Yrs) |
4.84250000098996E-08 |
| Normal-vs-Age(81-100Yrs) |
1.961640E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.560200E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.824600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.011600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.018600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.441400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.500200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.884000E-01 |
| Classical-VS-Follicular |
6.592600E-01 |
| Classical-VS-Other |
3.733200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
5.923600E-01 |
| Tall-VS-Other |
6.294200E-01 |
| Tall-VS-Normal |
1.446970E-04 |
| Follicular-VS-Other |
4.678000E-01 |
| Follicular-VS-Normal |
2.06869998908843E-09 |
| Other-VS-Normal |
1.717000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.20694598549198E-14 |
| Normal-vs-N1 |
1.93400000014776E-07 |
| N0-vs-N1 |
6.152000E-01 |
|
|
